Endurance Wealth Management’s Biogen BIIB Stock Holding History

Endurance Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-65	Closed	-$15K	–	528
2019 Q2	$15K	Sell	65 -5,065	-99%	-$1.17M	﹤0.01%	356
2019 Q1	$1.21M	Hold	5,130	–	–	0.2%	89
2018 Q4	$1.54M	Sell	5,130 -70	-1%	-$22.3K	0.29%	79
2018 Q3	$1.84M	Hold	5,200	–	–	0.29%	77
2018 Q2	$1.51M	Hold	5,200	–	–	0.25%	81
2018 Q1	$1.42M	Hold	5,200	–	–	0.24%	84
2017 Q4	$1.66M	Hold	5,200	–	–	0.27%	81
2017 Q3	$1.63M	Hold	5,200	–	–	0.27%	78
2017 Q2	$1.41M	Hold	5,200	–	–	0.24%	82
2017 Q1	$1.42M	Buy	5,200 +200	+4%	+$56.5K	0.25%	84
2016 Q4	$1.42M	Hold	5,000	–	–	0.25%	83
2016 Q3	$1.52M	Hold	5,000	–	–	0.27%	79
2016 Q2	$1.21M	Hold	5,000	–	–	0.23%	90
2016 Q1	$1.3K	Hold	5,000	–	–	0.18%	82
2015 Q4	$1.53M	Hold	5,000	–	–	0.29%	77
2015 Q3	$1.32M	Hold	5,000	–	–	0.23%	88
2015 Q2	$2.02M	Hold	5,000	–	–	0.34%	72
2015 Q1	$2.11M	Hold	5,000	–	–	0.37%	67
2014 Q4	$1.7M	Hold	5,000	–	–	0.3%	77
2014 Q3	$1.65M	Hold	5,000	–	–	0.31%	74
2014 Q2	$1.58M	Hold	5,000	–	–	0.26%	83
2014 Q1	$1.53M	Hold	5,000	–	–	0.3%	74
2013 Q4	$1.4M	Hold	5,000	–	–	0.28%	75
2013 Q3	$1.2M	Hold	5,000	–	–	0.25%	78
2013 Q2	$1.08M	Buy	+5,000	New	+$1.07M	0.24%	88

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Endurance Wealth Management's BIIB Position: Q3 2019 in Review

Endurance Wealth Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 65 shares — an estimated $15K sold.

Endurance Wealth Management first reported a position in BIIB in Q2 2013 and held it in 25 quarters. The position peaked at $2.11M in Q1 2015. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Endurance Wealth Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Endurance Wealth Management sold 65 Biogen shares in Q3 2019, an estimated $15K.
Endurance Wealth Management first reported a position in Biogen in Q2 2013 and held it in 25 quarters.
Endurance Wealth Management's Biogen position peaked at $2.11M in Q1 2015.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Endurance Wealth Management's 13F filing for Q3 2019, filed 18 Oct 2019.